These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20383727)

  • 41. Thrombophilia, clinical factors, and recurrent venous thrombotic events.
    Christiansen SC; Cannegieter SC; Koster T; Vandenbroucke JP; Rosendaal FR
    JAMA; 2005 May; 293(19):2352-61. PubMed ID: 15900005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ABO blood groups and increased risk for the development of vascular involvement in Behçet's disease.
    Bektas E; Büyükdemir A; Yalcinkaya Y; Artim Esen B; Inanc M; Gül A
    Clin Exp Rheumatol; 2024 Oct; 42(10):2071-2075. PubMed ID: 39404478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Frequency and predictive factors of venous thrombosis in Behçet's disease].
    Ha-Ou-Nou FZ; Essaadouni L
    Rev Med Interne; 2020 Sep; 41(9):578-582. PubMed ID: 32471710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behçet's disease.
    Ateş A; Düzgün N; Ulu A; Tiryaki AO; Akar N
    Pathophysiol Haemost Thromb; 2003; 33(3):157-63. PubMed ID: 15170396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet's patients.
    Tunc SE; Aksu K; Keser G; Oksel F; Doganavsargil E; Pirildar T; Turk T; Terzioglu E; Huseyinov A
    Rheumatol Int; 2005 Jun; 25(5):326-31. PubMed ID: 15004723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma homocysteine level in patients with Behcet's disease with or without thrombosis.
    Shahram F; Faridar A; Hamedani MG; Nadji A; Naderi N; Mojarad Shafiee N; Rasker JJ; Davatchi F
    Arch Iran Med; 2010 Nov; 13(6):476-81. PubMed ID: 21039001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The evaluation of coagulation parameters and vessel involvement in Behcet' s disease. A clinical experience of Behcet' s disease: study of 152 cases.
    Harman E; Sayarlıoglu M; Harman M; Sayarlıoglu H
    Acta Med Iran; 2013 May; 51(4):215-23. PubMed ID: 23690099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein S deficiency and antibodies to protein S in patients with Behçet's disease.
    Guermazi S; Hamza M; Dellagi K
    Thromb Res; 1997 May; 86(3):197-204. PubMed ID: 9175241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factor V Leiden mutation in patients with Behçet's disease.
    Oner AF; Gürgey A; Gürler A; Mesci L
    J Rheumatol; 1998 Mar; 25(3):496-8. PubMed ID: 9517770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activated protein C resistance and its correlation with thrombophlebitis in Behçet's disease.
    Kavala M; Namdar ND; Kocatürk E; Türkoğlu Z; Zindanci I
    Acta Dermatovenerol Croat; 2011; 19(2):87-90. PubMed ID: 21703154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease.
    Sertoglu E; Omma A; Yucel C; Colak S; Sandıkcı SC; Ozgurtas T
    Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac complications in Behçet's disease.
    Türsen U; Ulubas B; Kaya TI; Pekdemirt H; Ikizoğlu G
    Clin Exp Dermatol; 2002 Nov; 27(8):651-3. PubMed ID: 12472538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dyslipidaemia in Behcet's disease as a thrombotic risk factor.
    Ricart JM; Vayá A; Santaolaria M; España F; Aznar J
    Ann Rheum Dis; 2006 Sep; 65(9):1248-9. PubMed ID: 16905584
    [No Abstract]   [Full Text] [Related]  

  • 54. Thrombosis in Behçet's disease: a retrospective survey from a single UK centre.
    Ames PR; Steuer A; Pap A; Denman AM
    Rheumatology (Oxford); 2001 Jun; 40(6):652-5. PubMed ID: 11426022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in Behçet's disease.
    Ricart JM; España F; Navarro S; Todolí J; Miguel De la Fuente J; Vayá A
    Clin Hemorheol Microcirc; 2013 Jan; 54(1):51-7. PubMed ID: 22750994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease.
    Atzeni F; Boiardi L; Nicoli D; Farnetti E; Casali B; Sarzi-Puttini P; Pipitone N; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Filippini D; Paolazzi G; Salvarani C
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S38-43. PubMed ID: 21813062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
    Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.
    Mader R; Ziv M; Adawi M; Mader R; Lavi I
    J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
    Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High levels of endothelial progenitor cells can be associated with thrombosis in patients with Behçet's disease.
    Bozkirli ED; Keşkek SÖ; Kozanoğlu I; Yücel AE
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S49-53. PubMed ID: 24774036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.